葡萄糖氧化酶作为药用植物抗糖尿病活性评价的模式酶:体外和计算机证据

C. Ashande, Adrien Masunda, K. Ngbolua, J. T. Kilembe, A. Matondo, Inkoto Liyongo Clément, Gbolo Zoawe Benjamin, Lengbiye Moke Emmanuel, D. Tshibangu, D. Tshilanda, P. Mpiana, V. Mudogo
{"title":"葡萄糖氧化酶作为药用植物抗糖尿病活性评价的模式酶:体外和计算机证据","authors":"C. Ashande, Adrien Masunda, K. Ngbolua, J. T. Kilembe, A. Matondo, Inkoto Liyongo Clément, Gbolo Zoawe Benjamin, Lengbiye Moke Emmanuel, D. Tshibangu, D. Tshilanda, P. Mpiana, V. Mudogo","doi":"10.53365/nrfhh/144779","DOIUrl":null,"url":null,"abstract":"Diabetes mellitus is a major public health problem in the world. In Africa, more than 80% of patients use plants for their treatment. However, the methods of validation of endogenous knowledge usually used are costly. The alternative method developed in this study aims at creating hyperglycemia <i>in vitro</i> and exploiting the metabolic pathway involving glucose oxidase for UV-visible spectrophotometric screening of medicinal plants’ antidiabetic activity. The evolution of glucose oxidation as a function of drug concentration is followed by UV-visible spectrophotometry. The formation of the stable complex between the enzyme and the inhibitor is studied using molecular docking. Drugs used (Gliben) and plant extracts exhibited an <i>in vitro</i> hypoglycemic effect by reducing exponentially, <i>in vitro</i>, the level of free glucose. The results also showed that <i>L. multiflora</i> is more active than <i>V. amygdalina</i> (IC<sub>50</sub>: 1.36 ± 0.09 mg/mL Vs IC<sub>50</sub>: 3.00 ± 0.54 mg/mL). Gliben (0.5 mg/mL) and <i>L. multiflora</i> (2 mg/mL) reduced both the rate of oxidation of glucose by glucose oxidase (catalytic power V<sub>max</sub>: 0.84 ± 0.11 mg*mL<sup>-1</sup>*min<sup>-1</sup> for Gliben and 1.72 ± 0.13 mg*mL<sup>-1</sup>*min<sup>-1</sup> for <sup>L. multiflora</sup>); and the affinity of this enzyme for its substrate-glucose (K<sub>M</sub>: 15.11 ± 2.72 mg*mL<sup>-1</sup> for Gliben and 9.17 ± 1.56 mg*mL<sup>-1</sup> for <i>L. multiflora</i>) when these results are compared to enzyme catalysis in the absence of inhibitor (V<sub>max</sub>: 2.86 ± 0.44 mg*mL<sup>-1</sup>*min-1; K<sub>M</sub>: 8.07 ± 1.96 mg*mL<sup>-1</sup>). The binding of GOX (1GAL) to selected phytocompounds derived from <i>L. multiflora</i> was confirmed by molecular docking. The most stable complexes were obtained for four compounds; <b>8</b> (-10.1±0.0 Kcal/mol), <b>6</b> (-9.5±0.1 Kcal/mol), <b>3</b> (-8.3±0.0 Kcal/mol) and <b>9</b> (-8.2±0.1 Kcal/mol). Among these, compounds <b>8</b> and <b>6</b> formed complexes with the enzyme stabilized by hydrogen bonds, the compound <b>8</b> forms 5 hydrogen bonds (<b>ASN514</b>, <b>ASP424</b>, <b>ARG95</b>, <b>TYP68</b>, <b>LEU65</b>) while compound <b>6</b> forms 2 hydrogen bonds (<b>ASN514</b> and <b>SER422</b>). However, no H-bonding interaction occurs in the complex that involves ligands <b>9</b> and <b>3</b> despite their high binding energy (-8.2±0.1 Kcal/mol and -8.3±0.0 Kcal/mol respectively). Glucose oxidase can serve as a marker enzyme for<i> in vitro</i> antidiabetic activity evaluation of medicinal plants.","PeriodicalId":394827,"journal":{"name":"Natural Resources for Human Health","volume":"6 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Glucose oxidase as a model enzyme for antidiabetic activity evaluation of medicinal plants: In vitro and in silico evidence\",\"authors\":\"C. Ashande, Adrien Masunda, K. Ngbolua, J. T. Kilembe, A. Matondo, Inkoto Liyongo Clément, Gbolo Zoawe Benjamin, Lengbiye Moke Emmanuel, D. Tshibangu, D. Tshilanda, P. Mpiana, V. Mudogo\",\"doi\":\"10.53365/nrfhh/144779\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Diabetes mellitus is a major public health problem in the world. In Africa, more than 80% of patients use plants for their treatment. However, the methods of validation of endogenous knowledge usually used are costly. The alternative method developed in this study aims at creating hyperglycemia <i>in vitro</i> and exploiting the metabolic pathway involving glucose oxidase for UV-visible spectrophotometric screening of medicinal plants’ antidiabetic activity. The evolution of glucose oxidation as a function of drug concentration is followed by UV-visible spectrophotometry. The formation of the stable complex between the enzyme and the inhibitor is studied using molecular docking. Drugs used (Gliben) and plant extracts exhibited an <i>in vitro</i> hypoglycemic effect by reducing exponentially, <i>in vitro</i>, the level of free glucose. The results also showed that <i>L. multiflora</i> is more active than <i>V. amygdalina</i> (IC<sub>50</sub>: 1.36 ± 0.09 mg/mL Vs IC<sub>50</sub>: 3.00 ± 0.54 mg/mL). Gliben (0.5 mg/mL) and <i>L. multiflora</i> (2 mg/mL) reduced both the rate of oxidation of glucose by glucose oxidase (catalytic power V<sub>max</sub>: 0.84 ± 0.11 mg*mL<sup>-1</sup>*min<sup>-1</sup> for Gliben and 1.72 ± 0.13 mg*mL<sup>-1</sup>*min<sup>-1</sup> for <sup>L. multiflora</sup>); and the affinity of this enzyme for its substrate-glucose (K<sub>M</sub>: 15.11 ± 2.72 mg*mL<sup>-1</sup> for Gliben and 9.17 ± 1.56 mg*mL<sup>-1</sup> for <i>L. multiflora</i>) when these results are compared to enzyme catalysis in the absence of inhibitor (V<sub>max</sub>: 2.86 ± 0.44 mg*mL<sup>-1</sup>*min-1; K<sub>M</sub>: 8.07 ± 1.96 mg*mL<sup>-1</sup>). The binding of GOX (1GAL) to selected phytocompounds derived from <i>L. multiflora</i> was confirmed by molecular docking. The most stable complexes were obtained for four compounds; <b>8</b> (-10.1±0.0 Kcal/mol), <b>6</b> (-9.5±0.1 Kcal/mol), <b>3</b> (-8.3±0.0 Kcal/mol) and <b>9</b> (-8.2±0.1 Kcal/mol). Among these, compounds <b>8</b> and <b>6</b> formed complexes with the enzyme stabilized by hydrogen bonds, the compound <b>8</b> forms 5 hydrogen bonds (<b>ASN514</b>, <b>ASP424</b>, <b>ARG95</b>, <b>TYP68</b>, <b>LEU65</b>) while compound <b>6</b> forms 2 hydrogen bonds (<b>ASN514</b> and <b>SER422</b>). However, no H-bonding interaction occurs in the complex that involves ligands <b>9</b> and <b>3</b> despite their high binding energy (-8.2±0.1 Kcal/mol and -8.3±0.0 Kcal/mol respectively). Glucose oxidase can serve as a marker enzyme for<i> in vitro</i> antidiabetic activity evaluation of medicinal plants.\",\"PeriodicalId\":394827,\"journal\":{\"name\":\"Natural Resources for Human Health\",\"volume\":\"6 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Natural Resources for Human Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.53365/nrfhh/144779\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Natural Resources for Human Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53365/nrfhh/144779","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

摘要

糖尿病是世界上一个主要的公共卫生问题。在非洲,超过80%的患者使用植物进行治疗。然而,通常使用的验证内生知识的方法成本很高。本研究开发的替代方法旨在体外产生高血糖,并利用葡萄糖氧化酶的代谢途径进行紫外可见分光光度法筛选药用植物的抗糖尿病活性。紫外可见分光光度法测定了葡萄糖氧化随药物浓度变化的过程。利用分子对接的方法研究了酶与抑制剂之间稳定络合物的形成。所使用的药物(Gliben)和植物提取物通过在体外指数降低游离葡萄糖水平而显示出体外降糖作用。多花乳酸菌的IC50为1.36±0.09 mg/mL, IC50为3.00±0.54 mg/mL。Gliben (0.5 mg/mL)和L. multiflora (2 mg/mL)均能降低葡萄糖氧化酶对葡萄糖的氧化速率(催化功率Vmax: Gliben为0.84±0.11 mg*mL-1*min-1, L. multiflora为1.72±0.13 mg*mL-1*min-1);与无抑制剂(Vmax: 2.86±0.44 mg*mL-1*min-1)时相比,该酶对底物葡萄糖的亲和力(Gliben为15.11±2.72 mg*mL-1, L. multiflora为9.17±1.56 mg*mL-1);KM: 8.07±1.96 mg*mL-1)。通过分子对接,证实了GOX (1GAL)与多花乳草中所选植物化合物的结合。四种化合物得到了最稳定的配合物;8(-10.1±0.0千卡每摩尔),6(-9.5±0.1千卡每摩尔),3(-8.3±0.0千卡每摩尔)和9(-8.2±0.1千卡每摩尔)。其中化合物8、6与被氢键稳定的酶形成配合物,化合物8形成5个氢键(ASN514、ASP424、ARG95、TYP68、LEU65),化合物6形成2个氢键(ASN514、SER422)。然而,配体9和配体3虽然结合能高(分别为-8.2±0.1 Kcal/mol和-8.3±0.0 Kcal/mol),但在配合物中没有发生氢键相互作用。葡萄糖氧化酶可作为药用植物体外抗糖尿病活性评价的标记酶。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Glucose oxidase as a model enzyme for antidiabetic activity evaluation of medicinal plants: In vitro and in silico evidence
Diabetes mellitus is a major public health problem in the world. In Africa, more than 80% of patients use plants for their treatment. However, the methods of validation of endogenous knowledge usually used are costly. The alternative method developed in this study aims at creating hyperglycemia in vitro and exploiting the metabolic pathway involving glucose oxidase for UV-visible spectrophotometric screening of medicinal plants’ antidiabetic activity. The evolution of glucose oxidation as a function of drug concentration is followed by UV-visible spectrophotometry. The formation of the stable complex between the enzyme and the inhibitor is studied using molecular docking. Drugs used (Gliben) and plant extracts exhibited an in vitro hypoglycemic effect by reducing exponentially, in vitro, the level of free glucose. The results also showed that L. multiflora is more active than V. amygdalina (IC50: 1.36 ± 0.09 mg/mL Vs IC50: 3.00 ± 0.54 mg/mL). Gliben (0.5 mg/mL) and L. multiflora (2 mg/mL) reduced both the rate of oxidation of glucose by glucose oxidase (catalytic power Vmax: 0.84 ± 0.11 mg*mL-1*min-1 for Gliben and 1.72 ± 0.13 mg*mL-1*min-1 for L. multiflora); and the affinity of this enzyme for its substrate-glucose (KM: 15.11 ± 2.72 mg*mL-1 for Gliben and 9.17 ± 1.56 mg*mL-1 for L. multiflora) when these results are compared to enzyme catalysis in the absence of inhibitor (Vmax: 2.86 ± 0.44 mg*mL-1*min-1; KM: 8.07 ± 1.96 mg*mL-1). The binding of GOX (1GAL) to selected phytocompounds derived from L. multiflora was confirmed by molecular docking. The most stable complexes were obtained for four compounds; 8 (-10.1±0.0 Kcal/mol), 6 (-9.5±0.1 Kcal/mol), 3 (-8.3±0.0 Kcal/mol) and 9 (-8.2±0.1 Kcal/mol). Among these, compounds 8 and 6 formed complexes with the enzyme stabilized by hydrogen bonds, the compound 8 forms 5 hydrogen bonds (ASN514, ASP424, ARG95, TYP68, LEU65) while compound 6 forms 2 hydrogen bonds (ASN514 and SER422). However, no H-bonding interaction occurs in the complex that involves ligands 9 and 3 despite their high binding energy (-8.2±0.1 Kcal/mol and -8.3±0.0 Kcal/mol respectively). Glucose oxidase can serve as a marker enzyme for in vitro antidiabetic activity evaluation of medicinal plants.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信